These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 28521610

  • 1. SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells.
    Liu H, Ma Y, He HW, Zhao WL, Shao RG.
    Autophagy; 2017 May 04; 13(5):900-913. PubMed ID: 28521610
    [Abstract] [Full Text] [Related]

  • 2. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.
    Bao M, Chen Z, Xu Y, Zhao Y, Zha R, Huang S, Liu L, Chen T, Li J, Tu H, He X.
    Liver Int; 2012 Feb 04; 32(2):331-8. PubMed ID: 22098666
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-506-3p initiates mesenchymal-to-epithelial transition and suppresses autophagy in osteosarcoma cells by directly targeting SPHK1.
    Wang D, Bao F, Teng Y, Li Q, Li J.
    Biosci Biotechnol Biochem; 2019 May 04; 83(5):836-844. PubMed ID: 30669957
    [Abstract] [Full Text] [Related]

  • 4. Sphingosine-1-phosphate promotes pulmonary artery smooth muscle cells proliferation by stimulating autophagy-mediated E-cadherin/CDH1 down-regulation.
    Zhai C, Feng W, Shi W, Wang J, Zhang Q, Yan X, Wang Q, Li S, Liu L, Pan Y, Zhu Y, Chai L, Li C, Liu P, Chen Y, Li M.
    Eur J Pharmacol; 2020 Oct 05; 884():173302. PubMed ID: 32659302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.
    J Cell Mol Med; 2011 Mar 05; 15(3):691-700. PubMed ID: 20219012
    [Abstract] [Full Text] [Related]

  • 9. SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells.
    Xu CY, Liu SQ, Qin MB, Zhuge CF, Qin L, Qin N, Lai MY, Huang JA.
    Int J Mol Med; 2017 May 05; 39(5):1277-1284. PubMed ID: 28405684
    [Abstract] [Full Text] [Related]

  • 10. SPHK1 potentiates colorectal cancer progression and metastasis via regulating autophagy mediated by TRAF6-induced ULK1 ubiquitination.
    Chen D, Wu J, Qiu X, Luo S, Huang S, Wei E, Qin M, Huang J, Liu S.
    Cancer Gene Ther; 2024 Mar 05; 31(3):410-419. PubMed ID: 38135696
    [Abstract] [Full Text] [Related]

  • 11. SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma.
    Zhang Z, Yan Z, Yuan Z, Sun Y, He H, Mai C.
    Tumour Biol; 2015 Mar 05; 36(3):1503-9. PubMed ID: 25537088
    [Abstract] [Full Text] [Related]

  • 12. Sphingosine 1-phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells.
    Wang W, Hind T, Lam BWS, Herr DR.
    FASEB J; 2019 Jun 05; 33(6):7180-7191. PubMed ID: 30844311
    [Abstract] [Full Text] [Related]

  • 13. SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells.
    Sun T, Jiao L, Wang Y, Yu Y, Ming L.
    Cell Death Dis; 2018 Jan 26; 9(2):136. PubMed ID: 29374154
    [Abstract] [Full Text] [Related]

  • 14. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ, Pan Q, Wang SM, Pan YC, Wang Q, Zhang HH, Zhu MH, Zhang SH.
    Tumour Biol; 2016 Aug 26; 37(8):11457-67. PubMed ID: 27010469
    [Abstract] [Full Text] [Related]

  • 15. Role of Sphk1 in the malignant transformation of breast epithelial cells and breast cancer progression.
    Zheng XD, Zhang Y, Qi XW, Wang MH, Sun P, Zhang Y, Jiang J.
    Indian J Cancer; 2014 Aug 26; 51(4):524-9. PubMed ID: 26842184
    [Abstract] [Full Text] [Related]

  • 16. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition.
    Li J, Yang B, Zhou Q, Wu Y, Shang D, Guo Y, Song Z, Zheng Q, Xiong J.
    Carcinogenesis; 2013 Jun 26; 34(6):1343-51. PubMed ID: 23430956
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
    Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM.
    Oncogene; 2014 Jul 31; 33(31):4069-76. PubMed ID: 24013226
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP, Xiao ZL, Yang Z, Li J, Feng GX, Chen FQ, Li YH, Feng JY, Gao YE, Ye LH, Zhang XD.
    Acta Pharmacol Sin; 2015 Oct 31; 36(10):1228-36. PubMed ID: 26073327
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 31; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 20. Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.
    Ying HY, Gong CJ, Feng Y, Jing DD, Lu LG.
    J Dig Dis; 2017 Jun 31; 18(6):349-358. PubMed ID: 28544403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.